|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 250.36 USD | -2.41% |
|
+0.97% | +9.66% |
| 04:13pm | ResMed Receives FDA Clearance for AI-Powered Device to Personalize Sleep Apnea Therapy | MT |
| 12-04 | Resmed Insider Sold Shares Worth $502,940, According to a Recent SEC Filing | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| US$293.47 | +14.39% | 15 | |||||||
| US$625.87 | +9.27% | 22 | |||||||
| US$596.36 | +3.65% | 29 | |||||||
| US$255.67 | +13% | 21 | |||||||
| US$126.48 | +29.7% | 32 | |||||||
| €57.09 | +31.22% | 19 | |||||||
| US$95.41 | +10.69% | 28 | |||||||
| US$169.4 | +16.43% | 15 | |||||||
| US$88.11 | +3.1% | 20 | |||||||
| CN¥280.05 | +38.37% | 21 | |||||||
| €26.99 | +15.98% | 17 | |||||||
| US$388.58 | -1.58% | 14 | |||||||
| US$121.39 | -5.87% | 18 | |||||||
| US$76.5 | +2.04% | 12 | |||||||
| JP¥2,077.69 | +2.48% | 13 | |||||||
| US$113.67 | +12.78% | 15 | |||||||
| US$48.83 | +1.67% | 12 | |||||||
| HK$10.12 | +7.13% | 3 | |||||||
| US$143 | +4.75% | 11 | |||||||
| €53.66 | +23.52% | 16 | |||||||
| Average | 282.42 | +11.64% | 18 | ||||||
| Weighted average by Cap. | 359.11 | +13.20% | 23 |
- Stock Market
- Equities
- RMD Stock
- Sector ResMed, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















